메뉴 건너뛰기




Volumn 2014, Issue , 2014, Pages

Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TRACER; ANTIMICROBIAL CATIONIC PEPTIDE; RADIOPHARMACEUTICAL AGENT;

EID: 84930333296     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/867381     Document Type: Review
Times cited : (178)

References (71)
  • 1
    • 79952176166 scopus 로고    scopus 로고
    • The evolution of imaging in cancer: Current state and future challenges
    • L. J. Higgins and M. G. Pomper, "The evolution of imaging in cancer: Current state and future challenges," Seminars in Oncology, vol. 38, no. 1, pp. 3-15, 2011.
    • (2011) Seminars in Oncology , vol.38 , Issue.1 , pp. 3-15
    • Higgins, L.J.1    Pomper, M.G.2
  • 2
    • 56349168880 scopus 로고    scopus 로고
    • Positron emission tomography as a diagnostic tool in infection: Present role and future possibilities
    • S. Basu, T. Chryssikos, S. Moghadam-Kia, H. Zhuang, D. A. Torigian, and A. Alavi, "Positron emission tomography as a diagnostic tool in infection: Present role and future possibilities," Seminars in Nuclear Medicine, vol. 39, no. 1, pp. 36-51, 2009.
    • (2009) Seminars in Nuclear Medicine , vol.39 , Issue.1 , pp. 36-51
    • Basu, S.1    Chryssikos, T.2    Moghadam-Kia, S.3    Zhuang, H.4    Torigian, D.A.5    Alavi, A.6
  • 3
    • 66149111064 scopus 로고    scopus 로고
    • Radionuclide imaging of infection: In search of the grail
    • C. J. Palestro, "Radionuclide imaging of infection: In search of the grail," Journal of Nuclear Medicine, vol. 50,no. 5, pp.671-673, 2009.
    • (2009) Journal of Nuclear Medicine , vol.50 , Issue.5 , pp. 671-673
    • Palestro, C.J.1
  • 5
    • 0035090670 scopus 로고    scopus 로고
    • Radiopharmaceuticals for scintigraphic imaging of infection and inflammation
    • O. C. Boerman, E. T.M. Dams,W. J.G.Oyen, F. H.M. Corstens, and G. Storm, "Radiopharmaceuticals for scintigraphic imaging of infection and inflammation," Inflammation Research, vol. 50, no. 2, pp. 55-64, 2001.
    • (2001) Inflammation Research , vol.50 , Issue.2 , pp. 55-64
    • Boerman, O.C.1    Dams, E.T.M.2    Oyen, W.J.G.3    Corstens, F.H.M.4    Storm, G.5
  • 7
    • 56749178651 scopus 로고    scopus 로고
    • Clinically proven radiopharmaceuticals for infection imaging: Mechanisms and applications
    • S. J. Goldsmith and S. Vallabhajosula, "Clinically proven radiopharmaceuticals for infection imaging: Mechanisms and applications," Seminars in Nuclear Medicine, vol. 39, no. 1, pp. 2-10, 2009.
    • (2009) Seminars in Nuclear Medicine , vol.39 , Issue.1 , pp. 2-10
    • Goldsmith, S.J.1    Vallabhajosula, S.2
  • 8
    • 44649154576 scopus 로고    scopus 로고
    • The pharmacology of radiolabeled cationic antimicrobial peptides
    • C. P. J. M. Brouwer, M. Wulferink, and M. M. Welling, "The pharmacology of radiolabeled cationic antimicrobial peptides," Journal of Pharmaceutical Sciences, vol. 97, no. 5, pp. 1633-1651, 2008.
    • (2008) Journal of Pharmaceutical Sciences , vol.97 , Issue.5 , pp. 1633-1651
    • Brouwer, C.P.J.M.1    Wulferink, M.2    Welling, M.M.3
  • 9
    • 0037371597 scopus 로고    scopus 로고
    • Mechanisms of antimicrobial peptide action and resistance
    • M. R. Yeaman and N. Y. Yount, "Mechanisms of antimicrobial peptide action and resistance," Pharmacological Reviews, vol. 55, no. 1, pp. 27-55, 2003.
    • (2003) Pharmacological Reviews , vol.55 , Issue.1 , pp. 27-55
    • Yeaman, M.R.1    Yount, N.Y.2
  • 10
    • 1942439836 scopus 로고    scopus 로고
    • Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases
    • S. M. Okarvi, "Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases," Medicinal Research Reviews, vol. 24, no. 3, pp. 357-397, 2004.
    • (2004) Medicinal Research Reviews , vol.24 , Issue.3 , pp. 357-397
    • Okarvi, S.M.1
  • 11
    • 77649237880 scopus 로고    scopus 로고
    • Antimicrobial peptides: General overview and clinical implications in human health and disease
    • E. Guaní-Guerra, T. Santos-Mendoza, S. O. Lugo-Reyes, and L. M. Terán, "Antimicrobial peptides: General overview and clinical implications in human health and disease," Clinical Immunology, vol. 135, no. 1, pp. 1-11, 2010.
    • (2010) Clinical Immunology , vol.135 , Issue.1 , pp. 1-11
    • Guaní-Guerra, E.1    Santos-Mendoza, T.2    Lugo-Reyes, S.O.3    Terán, L.M.4
  • 12
    • 0037165196 scopus 로고    scopus 로고
    • Antimicrobial peptides ofmulticellular organisms
    • M. Zasloff, "Antimicrobial peptides ofmulticellular organisms," Nature, vol. 415, no. 6870, pp. 389-395, 2002.
    • (2002) Nature , vol.415 , Issue.6870 , pp. 389-395
    • Zasloff, M.1
  • 13
    • 77955846576 scopus 로고    scopus 로고
    • Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity
    • D. Takahashi, S. K. Shukla, O. Prakash, and G. Zhang, "Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity," Biochimie, vol. 92, no. 9, pp. 1236-1241, 2010.
    • (2010) Biochimie , vol.92 , Issue.9 , pp. 1236-1241
    • Takahashi, D.1    Shukla, S.K.2    Prakash, O.3    Zhang, G.4
  • 14
    • 33748933561 scopus 로고    scopus 로고
    • Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies
    • I. Zelezetsky and A. Tossi, "Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies," Biochimica et Biophysica Acta, vol. 1758, no. 9, pp. 1436-1449, 2006.
    • (2006) Biochimica et Biophysica Acta , vol.1758 , Issue.9 , pp. 1436-1449
    • Zelezetsky, I.1    Tossi, A.2
  • 15
    • 0032717048 scopus 로고    scopus 로고
    • Diversity of antimicrobial peptides and their mechanisms of action
    • R. M. Epand and H. J. Vogel, "Diversity of antimicrobial peptides and their mechanisms of action," Biochimica et Biophysica Acta, vol. 1462, no. 1-2, pp. 11-28, 1999.
    • (1999) Biochimica et Biophysica Acta , vol.1462 , Issue.1-2 , pp. 11-28
    • Epand, R.M.1    Vogel, H.J.2
  • 16
    • 0035929565 scopus 로고    scopus 로고
    • Interaction of cationic antimicrobial peptides with model membranes
    • L. Zhang, A. Rozek, and R. E. W. Hancock, "Interaction of cationic antimicrobial peptides with model membranes," The Journal of Biological Chemistry, vol. 276, no. 38, pp. 35714-35722, 2001.
    • (2001) The Journal of Biological Chemistry , vol.276 , Issue.38 , pp. 35714-35722
    • Zhang, L.1    Rozek, A.2    Hancock, R.E.W.3
  • 17
    • 0033864862 scopus 로고    scopus 로고
    • Amphipathic, alphahelical antimicrobial peptides
    • A. Tossi, L. Sandri, and A. Giangaspero, "Amphipathic, alphahelical antimicrobial peptides," Biopolymers, vol. 55, no. 1, pp. 4-30, 2000.
    • (2000) Biopolymers , vol.55 , Issue.1 , pp. 4-30
    • Tossi, A.1    Sandri, L.2    Giangaspero, A.3
  • 18
    • 0032719739 scopus 로고    scopus 로고
    • Structural features of helical antimicrobial peptides: Their potential to modulate activity on model membranes and biological cells
    • M. Dathe and T. Wieprecht, "Structural features of helical antimicrobial peptides: Their potential to modulate activity on model membranes and biological cells," Biochimica et Biophysica Acta-Biomembranes, vol. 1462, no. 1-2, pp. 71-87, 1999.
    • (1999) Biochimica et Biophysica Acta-Biomembranes , vol.1462 , Issue.1-2 , pp. 71-87
    • Dathe, M.1    Wieprecht, T.2
  • 19
    • 0035807045 scopus 로고    scopus 로고
    • Membrane-spanning peptides induce phospholipid flop: Amodel for phospholipid translocation across the inner membrane of E coli
    • M. A. Kol, A. I. P. M. de Kroon, D. T. S. Rijkers, J. A. Killian, and B. De Kruijff, "Membrane-spanning peptides induce phospholipid flop: Amodel for phospholipid translocation across the inner membrane of E. coli," Biochemistry, vol. 40, no. 35, pp. 10500-10506, 2001.
    • (2001) Biochemistry , vol.40 , Issue.35 , pp. 10500-10506
    • Kol, M.A.1    De Kroon, A.I.P.M.2    Rijkers, D.T.S.3    Killian, J.A.4    De Kruijff, B.5
  • 20
    • 0034744067 scopus 로고    scopus 로고
    • 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections
    • M. M. Welling, A. Lupetti, H. S. Balter et al., "99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections," Journal of Nuclear Medicine, vol. 42, no. 5, pp. 788-794, 2001.
    • (2001) Journal of Nuclear Medicine , vol.42 , Issue.5 , pp. 788-794
    • Welling, M.M.1    Lupetti, A.2    Balter, H.S.3
  • 22
    • 0032693640 scopus 로고    scopus 로고
    • Interaction of antimicrobial peptides with biological and model membranes: Structural and charge requirements for activity
    • N. Sitaram and R. Nagaraj, "Interaction of antimicrobial peptides with biological and model membranes: Structural and charge requirements for activity," Biochimica et Biophysica Acta: Biomembranes, vol. 1462, no. 1-2, pp. 29-54, 1999.
    • (1999) Biochimica et Biophysica Acta: Biomembranes , vol.1462 , Issue.1-2 , pp. 29-54
    • Sitaram, N.1    Nagaraj, R.2
  • 23
    • 0035919725 scopus 로고    scopus 로고
    • Optimization of the antimicrobial activity of magainin peptides by modification of charge
    • M. Dathe, H. Nikolenko, J. Meyer, M. Beyermann, and M. Bienert, "Optimization of the antimicrobial activity of magainin peptides by modification of charge," FEBS Letters, vol. 501, no. 1-3, pp. 146-150, 2001.
    • (2001) FEBS Letters , vol.501 , Issue.1-3 , pp. 146-150
    • Dathe, M.1    Nikolenko, H.2    Meyer, J.3    Beyermann, M.4    Bienert, M.5
  • 24
    • 0036948138 scopus 로고    scopus 로고
    • Mode of action of membrane active antimicrobial peptides
    • Y. Shai, "Mode of action of membrane active antimicrobial peptides," Biopolymers, vol. 66, no. 4, pp. 236-248, 2002.
    • (2002) Biopolymers , vol.66 , Issue.4 , pp. 236-248
    • Shai, Y.1
  • 25
    • 0030957876 scopus 로고    scopus 로고
    • Peptide hydrophobicity controls the activity and selectivity ofmagainin 2 amide in interaction with membranes
    • T. Wieprecht, M. Dathe, M. Beyermann et al., "Peptide hydrophobicity controls the activity and selectivity ofmagainin 2 amide in interaction with membranes," Biochemistry, vol. 36, no. 20, pp. 6124-6132, 1997.
    • (1997) Biochemistry , vol.36 , Issue.20 , pp. 6124-6132
    • Wieprecht, T.1    Dathe, M.2    Beyermann, M.3
  • 26
    • 0033799243 scopus 로고    scopus 로고
    • Polar angle as a determinant of amphipathic α-helix-lipid interactions: A model peptide study
    • N. Uematsu and K.Matsuzaki, "Polar angle as a determinant of amphipathic α-helix-lipid interactions: A model peptide study," Biophysical Journal, vol. 79, no. 4, pp. 2075-2083, 2000.
    • (2000) Biophysical Journal , vol.79 , Issue.4 , pp. 2075-2083
    • Uematsu, N.1    Matsuzaki, K.2
  • 27
    • 0032693639 scopus 로고    scopus 로고
    • Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes
    • K. Matsuzaki, "Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes," Biochimica et Biophysica Acta-Biomembranes, vol. 1462, no. 1-2, pp. 1-10, 1999.
    • (1999) Biochimica et Biophysica Acta-Biomembranes , vol.1462 , Issue.1-2 , pp. 1-10
    • Matsuzaki, K.1
  • 28
    • 0141799911 scopus 로고    scopus 로고
    • Defensins: Antimicrobial peptides of innate immunity
    • T. Ganz, "Defensins: Antimicrobial peptides of innate immunity," Nature Reviews Immunology, vol. 3, no. 9, pp. 710-720, 2003.
    • (2003) Nature Reviews Immunology , vol.3 , Issue.9 , pp. 710-720
    • Ganz, T.1
  • 29
    • 0037099263 scopus 로고    scopus 로고
    • Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice
    • L.V.Collins, S. A.Kristian,C.Weidenmaier et al., "Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice," The Journal of Infectious Diseases, vol. 186, no. 2, pp. 214-219, 2002.
    • (2002) The Journal of Infectious Diseases , vol.186 , Issue.2 , pp. 214-219
    • Collins, L.V.1    Kristian, S.A.2    Weidenmaier, C.3
  • 30
    • 0035059332 scopus 로고    scopus 로고
    • Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces
    • M. Gross, S. E. Cramton, F. Götz, and A. Peschel, "Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces," Infection and Immunity, vol. 69, no. 5, pp. 3423-3426, 2001.
    • (2001) Infection and Immunity , vol.69 , Issue.5 , pp. 3423-3426
    • Gross, M.1    Cramton, S.E.2    Götz, F.3    Peschel, A.4
  • 31
    • 0036532403 scopus 로고    scopus 로고
    • How do bacteria resist human antimicrobial peptides?
    • A. Peschel, "How do bacteria resist human antimicrobial peptides?" Trends in Microbiology, vol. 10, no. 4, pp. 179-186, 2002.
    • (2002) Trends in Microbiology , vol.10 , Issue.4 , pp. 179-186
    • Peschel, A.1
  • 32
    • 67649256037 scopus 로고    scopus 로고
    • Control of cell selectivity of antimicrobial peptides
    • K. Matsuzaki, "Control of cell selectivity of antimicrobial peptides," Biochimica et Biophysica Acta, vol. 1788, no. 8, pp. 1687-1692, 2009.
    • (2009) Biochimica et Biophysica Acta , vol.1788 , Issue.8 , pp. 1687-1692
    • Matsuzaki, K.1
  • 33
    • 0028920870 scopus 로고
    • Structure-activity studies on magainins and other host defense peptides
    • W. L. Maloy and U. P. Kari, "Structure-activity studies on magainins and other host defense peptides," Biopolymers, vol. 37, no. 2, pp. 105-122, 1995.
    • (1995) Biopolymers , vol.37 , Issue.2 , pp. 105-122
    • Maloy, W.L.1    Kari, U.P.2
  • 34
    • 0033579207 scopus 로고    scopus 로고
    • Use of the cell wail precursor lipid II by a pore-forming peptide antibiotic
    • E. Breukink, I. Wiedemann, C. van Kraaij, O. P. Kuipers, H.-. Sahl, and B. de Kruijff, "Use of the cell wail precursor lipid II by a pore-forming peptide antibiotic," Science, vol. 286, no. 5448, pp. 2361-2364, 1999.
    • (1999) Science , vol.286 , Issue.5448 , pp. 2361-2364
    • Breukink, E.1    Wiedemann, I.2    Van Kraaij, C.3    Kuipers, O.P.4    Sahl, H.5    De Kruijff, B.6
  • 35
    • 0035910508 scopus 로고    scopus 로고
    • Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity," the
    • I.Wiedemann, E. Breukink, C. van Kraaij et al., "Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity," The Journal of Biological Chemistry, vol. 276, no. 3, pp. 1772-1779, 2001.
    • (2001) Journal of Biological Chemistry , vol.276 , Issue.3 , pp. 1772-1779
    • Wiedemann, I.1    Breukink, E.2    Van Kraaij, C.3
  • 36
    • 0032738473 scopus 로고    scopus 로고
    • Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: Determination and biological specificity
    • S. E. Blondelle, K. Lohner, and M. Aguilar, "Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: Determination and biological specificity," Biochimica et Biophysica Acta: Biomembranes, vol. 1462, no. 1-2, pp. 89-108, 1999.
    • (1999) Biochimica et Biophysica Acta: Biomembranes , vol.1462 , Issue.1-2 , pp. 89-108
    • Blondelle, S.E.1    Lohner, K.2    Aguilar, M.3
  • 37
    • 0033532175 scopus 로고    scopus 로고
    • Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity," the
    • L. H. Kondejewski, M. Jelokhani-Niaraki, S. W. Farmer et al., "Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity," The Journal of Biological Chemistry, vol. 274, no. 19, pp. 13181-13192, 1999.
    • (1999) Journal of Biological Chemistry , vol.274 , Issue.19 , pp. 13181-13192
    • Kondejewski, L.H.1    Jelokhani-Niaraki, M.2    Farmer, S.W.3
  • 38
    • 0033798839 scopus 로고    scopus 로고
    • Crystallization of antimicrobial pores in membranes: Magainin and protegrin
    • L. Yang, T. M. Weiss, R. I. Lehrer, and H. W. Huang, "Crystallization of antimicrobial pores in membranes: Magainin and protegrin," Biophysical Journal, vol. 79, no. 4, pp. 2002-2009, 2000.
    • (2000) Biophysical Journal , vol.79 , Issue.4 , pp. 2002-2009
    • Yang, L.1    Weiss, T.M.2    Lehrer, R.I.3    Huang, H.W.4
  • 39
    • 0034713831 scopus 로고    scopus 로고
    • Action of antimicrobial peptides: Two-state model
    • H. W. Huang, "Action of antimicrobial peptides: Two-state model," Biochemistry, vol. 39, no. 29, pp. 8347-8352, 2000.
    • (2000) Biochemistry , vol.39 , Issue.29 , pp. 8347-8352
    • Huang, H.W.1
  • 40
    • 0038052326 scopus 로고    scopus 로고
    • Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37
    • K. A. HenzlerWildman, D. Lee, and A. Ramamoorthy, "Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37," Biochemistry, vol. 42, no. 21, pp. 6545-6558, 2003.
    • (2003) Biochemistry , vol.42 , Issue.21 , pp. 6545-6558
    • Henzlerwildman, K.A.1    Lee, D.2    Ramamoorthy, A.3
  • 41
    • 12844268168 scopus 로고    scopus 로고
    • Peptide-lipid interactions: Insights and perspectives
    • J. M. Sanderson, "Peptide-lipid interactions: Insights and perspectives," Organic & Biomolecular Chemistry, vol. 3, no. 2, pp. 201-212, 2005.
    • (2005) Organic & Biomolecular Chemistry , vol.3 , Issue.2 , pp. 201-212
    • Sanderson, J.M.1
  • 42
    • 0034859096 scopus 로고    scopus 로고
    • Barrel-stavemodel or toroidalmodel?Acase study onmelittin pores
    • L. Yang, T. A. Harroun, T. M.Weiss, L. Ding, and H.W. Huang, "Barrel-stavemodel or toroidalmodel?Acase study onmelittin pores," Biophysical Journal, vol. 81, no. 3, pp. 1475-1485, 2001.
    • (2001) Biophysical Journal , vol.81 , Issue.3 , pp. 1475-1485
    • Yang, L.1    Harroun, T.A.2    Weiss, T.W.3    Ding, L.4    Huang, H.W.5
  • 43
    • 0032764166 scopus 로고    scopus 로고
    • A prospective study of fever in the intensive care unit
    • B. Circiumaru, G. Baldock, and J. A. Cohen, "A prospective study of fever in the intensive care unit," Intensive Care Medicine, vol. 25, no. 7, pp. 668-673, 1999.
    • (1999) Intensive Care Medicine , vol.25 , Issue.7 , pp. 668-673
    • Circiumaru, B.1    Baldock, G.2    Cohen, J.A.3
  • 44
    • 0035752726 scopus 로고    scopus 로고
    • The role of nuclear medicine in infection and inflammation
    • W. Becker and J. Meller, "The role of nuclear medicine in infection and inflammation," TheLancet Infectious Diseases, vol. 1, no. 5, pp. 326-333, 2001.
    • (2001) The Lancet Infectious Diseases , vol.1 , Issue.5 , pp. 326-333
    • Becker, W.1    Meller, J.2
  • 51
    • 0034106065 scopus 로고    scopus 로고
    • Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations
    • M. M. Welling, A. Paulusma-Annema, H. S. Balter, E. K. J. Pauwels, and P. H. Nibbering, "Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations," European Journal of Nuclear Medicine, vol. 27, no. 3, pp. 292-301, 2000.
    • (2000) European Journal of Nuclear Medicine , vol.27 , Issue.3 , pp. 292-301
    • Welling, M.M.1    Paulusma-Annema, A.2    Balter, H.S.3    Pauwels, E.K.J.4    Nibbering, P.H.5
  • 52
    • 19644363678 scopus 로고    scopus 로고
    • Antimicrobial peptide 99mTc-Ubiquicidin 29-41 as human infection-imaging agent: Clinical trial
    • M. S. Akhtar, A. Qaisar, J. Irfanullah et al., "Antimicrobial peptide 99mTc-Ubiquicidin 29-41 as human infection-imaging agent: Clinical trial," Journal of Nuclear Medicine, vol. 46, no. 4, pp. 567-573, 2005.
    • (2005) Journal of Nuclear Medicine , vol.46 , Issue.4 , pp. 567-573
    • Akhtar, M.S.1    Qaisar, A.2    Irfanullah, J.3
  • 53
    • 14544282377 scopus 로고    scopus 로고
    • Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?
    • K. A. Brogden, "Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?" Nature Reviews Microbiology, vol. 3, no. 3, pp. 238-250, 2005.
    • (2005) Nature Reviews Microbiology , vol.3 , Issue.3 , pp. 238-250
    • Brogden, K.A.1
  • 54
    • 77954243816 scopus 로고    scopus 로고
    • Clinical trial of specific imaging of infections
    • C. A. deMurphy, F. Gemmel, and J. Balter, "Clinical trial of specific imaging of infections," Nuclear Medicine Communications, vol. 31, no. 8, pp. 726-733, 2010.
    • (2010) Nuclear Medicine Communications , vol.31 , Issue.8 , pp. 726-733
    • Demurphy, C.A.1    Gemmel, F.2    Balter, J.3
  • 55
    • 84886086593 scopus 로고    scopus 로고
    • Utility of 99mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection
    • S. Saeed, J. Zafar, B. Khan et al., "Utility of 99mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection," European Journal of Nuclear Medicine and Molecular Imaging, vol. 40, no. 5, pp. 737-743, 2013.
    • (2013) European Journal of Nuclear Medicine and Molecular Imaging , vol.40 , Issue.5 , pp. 737-743
    • Saeed, S.1    Zafar, J.2    Khan, B.3
  • 56
    • 84866458453 scopus 로고    scopus 로고
    • 99mTc-labeled Ubiquicidin scintigraphy: A promisingmethod in hip prosthesis infection diagnosis
    • K. Aryana, A. Hootkani, R. Sadeghi et al., "99mTc-labeled Ubiquicidin scintigraphy: A promisingmethod in hip prosthesis infection diagnosis," NuklearMedizin, vol. 51, no. 4, pp. 133-139, 2012.
    • (2012) Nuklear Medizin , vol.51 , Issue.4 , pp. 133-139
    • Aryana, K.1    Hootkani, A.2    Sadeghi, R.3
  • 57
    • 84878943185 scopus 로고    scopus 로고
    • 99mtc-Ubiquicidin [29-41], a promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation
    • D. Beiki, G. Yousefi, B. Fallahi et al., "99mtc-Ubiquicidin [29-41], a promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation," Iranian Journal of Pharmaceutical Research, vol. 12, no. 2, pp. 347-353, 2013.
    • (2013) Iranian Journal of Pharmaceutical Research , vol.12 , Issue.2 , pp. 347-353
    • Beiki, D.1    Yousefi, G.2    Fallahi, B.3
  • 58
    • 79959973850 scopus 로고    scopus 로고
    • Role of99mTcubiquicidin 29-41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: A preliminary study
    • B. Nazari, Z. Azizmohammadi,M. Rajaei et al., "Role of99mTcubiquicidin 29-41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: A preliminary study," Nuclear Medicine Communications, vol. 32, no. 8, pp. 745-751, 2011.
    • (2011) Nuclear Medicine Communications , vol.32 , Issue.8 , pp. 745-751
    • Nazari, B.1    Azizmohammadi, Z.2    Rajaei, M.3
  • 59
    • 79959948162 scopus 로고    scopus 로고
    • Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging
    • M. Assadi, K. Vahdat, I. Nabipour et al., "Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging," Nuclear Medicine Communications, vol. 32, no. 8, pp. 716-723, 2011.
    • (2011) Nuclear Medicine Communications , vol.32 , Issue.8 , pp. 716-723
    • Assadi, M.1    Vahdat, K.2    Nabipour, I.3
  • 61
    • 84900396272 scopus 로고    scopus 로고
    • Technetium-99m-ubiquicidin scintigraphy in the detection of infective endocarditis
    • A. M. Taghizadeh, M. H. Mandegar, and M. Assadi, "Technetium-99m-ubiquicidin scintigraphy in the detection of infective endocarditis," Hellenic Journal of Nuclear Medicine, vol. 17, no. 1, pp. 47-48, 2014.
    • (2014) Hellenic Journal of Nuclear Medicine , vol.17 , Issue.1 , pp. 47-48
    • Taghizadeh, A.M.1    Mandegar, M.H.2    Assadi, M.3
  • 62
    • 44249106830 scopus 로고    scopus 로고
    • 68Ga-PET: A powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals
    • M. Fani, J. P. andré, and H. R.Maecke, "68Ga-PET: A powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals," Contrast Media & Molecular Imaging, vol. 3, no. 2, pp. 67-77, 2008.
    • (2008) Contrast Media & Molecular Imaging , vol.3 , Issue.2 , pp. 67-77
    • Fani, M.1    André, J.P.2    Maecke, H.R.3
  • 63
    • 84898785192 scopus 로고    scopus 로고
    • Peptide synthesis, characterization and 68Ga-radiolabeling of NOTAconjugated ubiquicidin fragments for prospective infection imaging with PET/CT
    • T. Ebenhan, N. Chadwick, M. M. Sathekge et al., "Peptide synthesis, characterization and 68Ga-radiolabeling of NOTAconjugated ubiquicidin fragments for prospective infection imaging with PET/CT," Nuclear Medicine and Biology, vol. 41, no. 5, pp. 390-400, 2014.
    • (2014) Nuclear Medicine and Biology , vol.41 , Issue.5 , pp. 390-400
    • Ebenhan, T.1    Chadwick, N.2    Sathekge, M.M.3
  • 64
    • 84897950253 scopus 로고    scopus 로고
    • Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging
    • T. Ebenhan, J. R. Zeevaart, J. D. Venter et al., "Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging," Journal of Nuclear Medicine, vol. 55, no. 2, pp. 308-314, 2014.
    • (2014) Journal of Nuclear Medicine , vol.55 , Issue.2 , pp. 308-314
    • Ebenhan, T.1    Zeevaart, J.R.2    Venter, J.D.3
  • 65
    • 0034332193 scopus 로고    scopus 로고
    • The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations
    • B. Agerberth, J. Charo, J.Werr et al., "The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations," Blood, vol. 96, no. 9, pp. 3086-3093, 2000.
    • (2000) Blood , vol.96 , Issue.9 , pp. 3086-3093
    • Agerberth, B.1    Charo, J.2    Werr, J.3
  • 66
    • 44849104310 scopus 로고    scopus 로고
    • Comparison of 99mTc-and 18F-ubiquicidin autoradiography to anti-Staphylococcus aureus immunofluorescence in rat muscle abscesses
    • D. Salber, J. Gunawan, K. J. Langen et al., "Comparison of 99mTc-and 18F-ubiquicidin autoradiography to anti-Staphylococcus aureus immunofluorescence in rat muscle abscesses," Journal of Nuclear Medicine, vol. 49, no. 6, pp. 995-999, 2008.
    • (2008) Journal of Nuclear Medicine , vol.49 , Issue.6 , pp. 995-999
    • Salber, D.1    Gunawan, J.2    Langen, K.J.3
  • 67
    • 9644287934 scopus 로고    scopus 로고
    • The synthetic n-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrugresistant Acinetobacter baumannii
    • L.Dijkshoorn, C. P. J. M. Brouwer, S. J. P. Bogaards, A.Nemec, P. J. Van Den Broek, and P. H. Nibbering, "The synthetic n-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrugresistant Acinetobacter baumannii," Antimicrobial Agents and Chemotherapy, vol. 48, no. 12, pp. 4919-4921, 2004.
    • (2004) Antimicrobial Agents and Chemotherapy , vol.48 , Issue.12 , pp. 4919-4921
    • Dijkshoorn, L.1    Brouwer, C.P.J.M.2    Bogaards, S.J.P.3    Nemec, A.4    Broek Den Van, P.J.5    Nibbering, P.H.6
  • 68
    • 80052724738 scopus 로고    scopus 로고
    • Discovery and development of a synthetic peptide derived fromlactoferrin for clinical use
    • C. P. J. M. Brouwer, M. Rahman, and M. M.Welling, "Discovery and development of a synthetic peptide derived fromlactoferrin for clinical use," Peptides, vol. 32, no. 9, pp. 1953-1963, 2011.
    • (2011) Peptides , vol.32 , Issue.9 , pp. 1953-1963
    • Brouwer, C.P.J.M.1    Rahman, M.2    Welling, M.M.3
  • 69
    • 84865309100 scopus 로고    scopus 로고
    • Imaging the membrane lytic activity of bioactive peptide latarcin 2a
    • A. Won, A. Ruscito, and A. Ianoul, "Imaging the membrane lytic activity of bioactive peptide latarcin 2a," Biochimica et Biophysica Acta-Biomembranes, vol. 1818, no. 12, pp. 3072-3080, 2012.
    • (2012) Biochimica et Biophysica Acta-Biomembranes , vol.1818 , Issue.12 , pp. 3072-3080
    • Won, A.1    Ruscito, A.2    Ianoul, A.3
  • 70
    • 15744406017 scopus 로고    scopus 로고
    • Integrin αvβ3-targeted imaging of lung cancer
    • X. Chen, E. Sievers, Y. Hou et al., "Integrin αvβ3-targeted imaging of lung cancer," Neoplasia, vol. 7, no. 3, pp. 271-279, 2005.
    • (2005) Neoplasia , vol.7 , Issue.3 , pp. 271-279
    • Chen, X.1    Sievers, E.2    Hou, Y.3
  • 71
    • 1542609189 scopus 로고    scopus 로고
    • 99mTc-labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus
    • P. H. Nibbering, M. M. Welling, A. Paulusma-Annema, C. P. J. M. Brouwer, A. Lupetti, and E. K. J. Pauwels, "99mTc-labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus," Journal of Nuclear Medicine, vol. 45, no. 2, pp. 321-326, 2004.
    • (2004) Journal of Nuclear Medicine , vol.45 , Issue.2 , pp. 321-326
    • Nibbering, P.H.1    Welling, M.M.2    Paulusma-Annema, A.3    Brouwer, C.P.J.M.4    Lupetti, A.5    Pauwels, E.K.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.